Within this context, COL11A1, a fibrillar collagen overexpressed in pathological conditions, has attracted attention due to its association with tumor progression, therapeutic resistance, and prognosis across multiple cancer types, including breast cancer [4,8]. This evidence concerns the gene COL11A1 and breast cancer.